{"Ticker": "BXP", "Company": "Boston Properties", "Sector": "Real Estate", "Updated": "2022-08-04", "Rating": {"Date": "2022-08-04", "Rating": "Downgrade", "Organization": "SMBC Nikko", "Rating_Change": "Outperform to Neutral", "Target_Change": "$93"}}
{"Ticker": "CRL", "Company": "Charles River Laboratories", "Sector": "Health Care", "Updated": "2022-08-04", "Rating": {"Date": "2022-08-04", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$350 to $250"}}
{"Ticker": "QRVO", "Company": "Qorvo", "Sector": "Information Technology", "Updated": "2022-08-04", "Rating": {"Date": "2022-08-04", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Market Perform", "Target_Change": "$108 to $100"}}
{"Ticker": "SO", "Company": "Southern Company", "Sector": "Utilities", "Updated": "2022-08-04", "Rating": {"Date": "2022-08-04", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$76 to $87"}}
{"Ticker": "UAA", "Company": "Under Armour (Class A)", "Sector": "Consumer Discretionary", "Updated": "2022-08-04", "Rating": {"Date": "2022-08-04", "Rating": "Downgrade", "Organization": "Robert W. Baird", "Rating_Change": "Outperform to Neutral", "Target_Change": "$12 to $10"}}
